Get the Stockscreener App
29.75
0.44%
-0.13
Azenta Inc stock is traded at $29.75, with a volume of 405.55K.
It is down -0.44% in the last 24 hours and down -2.78% over the past month.
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.
See More
Previous Close:
$29.88
Open:
$29.3
24h Volume:
405.55K
Relative Volume:
0.79
Market Cap:
$1.36B
Revenue:
$604.93M
Net Income/Loss:
$-31.91M
P/E Ratio:
-12.29
EPS:
-2.42
Net Cash Flow:
$45.67M
1W Performance:
+1.29%
1M Performance:
-2.78%
6M Performance:
+10.43%
1Y Performance:
-30.21%
1-Day Range:
$29.17
$30.04
1-Week Range:
$29.17
$31.16
52-Week Range:
$23.91
$55.63
Azenta Inc Stock (AZTA) Company Profile
Name
Azenta Inc
Sector
Industry
Phone
(978) 262-2400
Address
200 SUMMIT DRIVE, BURLINGTON
Compare AZTA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AZTA
Azenta Inc
|
29.75 | 1.37B | 604.93M | -31.91M | 45.67M | -2.42 |
|
ISRG
Intuitive Surgical Inc
|
549.51 | 200.47B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
193.04 | 55.33B | 21.84B | 1.68B | 2.67B | 5.8322 |
|
ALC
Alcon Inc
|
77.65 | 38.61B | 10.19B | 1.05B | 1.39B | 2.1065 |
|
RMD
Resmed Inc
|
244.46 | 36.80B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
261.36 | 19.18B | 2.96B | 487.70M | 344.00M | 6.6758 |
Azenta Inc Stock (AZTA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-30-25 | Upgrade | Jefferies | Hold → Buy |
| Aug-06-25 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jul-22-25 | Resumed | Stephens | Equal-Weight |
| Dec-18-24 | Upgrade | Stephens | Equal-Weight → Overweight |
| Apr-04-24 | Initiated | Jefferies | Hold |
| Feb-01-24 | Reiterated | B. Riley Securities | Buy |
| Jul-19-23 | Initiated | Raymond James | Mkt Perform |
| May-10-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-09-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Mar-31-22 | Resumed | B. Riley Securities | Buy |
| Mar-21-22 | Initiated | Evercore ISI | Outperform |
View All
Azenta Inc Stock (AZTA) Latest News
How Azenta Inc. (BA3) stock responds to job market shiftsJobs Report & Expert Curated Trade Setups - newser.com
Is Azenta Inc. (BA3) stock at risk of policy regulationMarket Performance Report & Daily Risk Controlled Trade Plans - newser.com
Why institutional investors increase stakes in Azenta Inc. (BA3) stock2025 Top Decliners & Safe Swing Trade Setups - newser.com
Should I hold or sell Azenta Inc. stock in 2025Earnings Performance Report & Free Community Supported Trade Ideas - newser.com
Why Azenta Inc. stock is popular among millennialsJuly 2025 Sector Moves & Fast Entry and Exit Trade Plans - newser.com
Backtesting results for Azenta Inc. trading strategiesWeekly Trade Analysis & Technical Buy Zone Confirmations - newser.com
Using data tools to time your Azenta Inc. exitAnalyst Upgrade & Advanced Swing Trade Entry Plans - newser.com
Is Azenta Inc. (BA3) stock a top hedge fund pickWeekly Trade Review & Free Technical Confirmation Trade Alerts - newser.com
Is Azenta Inc. stock oversold or undervaluedJuly 2025 Setups & High Accuracy Swing Trade Signals - Fundação Cultural do Pará
Is Azenta Inc. stock vulnerable to regulatory risks2025 Valuation Update & Trade Opportunity Analysis Reports - newser.com
How Azenta Inc. (BA3) stock compares with tech leaders2025 Price Action Summary & Verified Technical Signals - newser.com
Will Azenta Inc. stock keep outperforming rivalsMarket Trend Report & High Return Trade Guides - newser.com
Using data models to predict Azenta Inc. stock movementEarnings Overview Summary & Weekly Sector Rotation Insights - newser.com
Pancreatic Cancer Research Partnership Could Be a Game Changer for Azenta (AZTA) - simplywall.st
Why Azenta Inc. (BA3) stock appeals to dividend investorsJuly 2025 Rallies & Real-Time Volume Spike Alerts - newser.com
Can Azenta Inc. (BA3) stock sustain margin levelsForecast Cut & Fast Entry High Yield Tips - newser.com
Azenta Announces Fiscal 2025 Fourth Quarter and Full Year Conference Call and Webcast - Eastern Progress
Is Azenta Inc. stock a buy in volatile marketsJuly 2025 Institutional & Real-Time Chart Pattern Alerts - newser.com
Long term hold vs stop loss in Azenta Inc.Quarterly Trade Report & Verified Momentum Stock Alerts - newser.com
Live market analysis of Azenta Inc.Product Launch & Fast Exit/Entry Strategy Plans - newser.com
Azenta (Nasdaq: AZTA) sets earnings call for Q4 and full-year results on Nov. 21 - Stock Titan
Azenta, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Why analysts upgrade Azenta Inc. stock2025 Breakouts & Breakdowns & Safe Entry Zone Tips - newser.com
Azenta Inc Stock (AZTA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.23%
0.58%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):